FDA Classified Major Tomato Recall Now Classified as Deadly
Last month, Ray & Mascari Inc., an Indiana-based company, issued a recall on its 4-count packs of Vine-Ripe Tomatoes due to potential salmonella contamination. But the FDA has now elevated that recall, warning that the tomatoes could cause "serious adverse health consequences or death."
While it is unlikely that the affected tomatoes will still be sitting on your countertops, the agency urges consumers to double-check their freezers for any tomatoes that may be stored there.
Gordon Food Service Stores initially sold the recalled tomatoes in numerous states, including New York, Illinois, Indiana, Michigan, Kentucky, Pennsylvania, Tennessee, Missouri, Wisconsin, and Mississippi. The affected products were packaged in clamshell containers with the UPC #7 96553 20062 1 and a master case label with Lot # RM250424 15250B or Lot # RM250427 15250B
The update to a Class I, the most severe type of FDA recall, affects packages sold in Georgia, North Carolina, and South Carolina under the name H&C Farms Label. These tomatoes came in various sizes, from 3-packs to 25-pound bags, and were sold between April 23 and April 28.
Salmonella is a potentially deadly infection that can cause symptoms such as diarrhea, nausea, vomiting, fever, and in rare cases, endocarditis, arthritis, and arterial infections. According to the CDC, roughly 420 people die from acute salmonellosis each year in the United States. The organization urges anyone with symptoms resembling Salmonella to consult their healthcare provider.
If you discover you have any of the affected tomatoes still in your possession, you should discard the product and avoid consuming it, per the recall.
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Kaiser cuts dozens of Bay Area jobs in latest round of statewide layoffs
SAN FRANCISCO (KRON) — Kaiser cut dozens of jobs across the Bay Area this week in the latest round of statewide layoffs from the health care provider. The layoffs will impact personnel at Kaiser Foundation Hospitals across the state, according to a filing with the Employment Development Department. In the Bay Area, a total of 40 jobs will be cut with layoffs impacting facilities in Oakland, Berkeley, Fremont, Pleasanton, San Francisco, and Vallejo. Statewide, a total of 55 jobs will be cut with layoffs impacting workers in Harbor City, Pasadena, Walnut, Fair Oaks, Los Angeles County, Yorba Linda, Irvine, Roseville, and San Diego. What's behind the ongoing Bay Area tech layoffs? 'Nobody is safe,' expert says The job cuts were announced on Monday and took immediate effect. All of the layoffs were described as permanent in state filings. The latest layoffs follow a previous round of job cuts at Kaiser back in April when the Oakland-based health care provider cut 40 jobs across the state, including 17 in the Bay Area. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Coal mines on Alberta's eastern slopes could push fishery 'beyond recovery': study
CALGARY — Old coal mines on the eastern slopes of the Alberta Rockies are leaching chemicals that are poisoning the fish downstream, says a new study by Alberta government scientists. It also suggests any new coal developments could result in "population collapse" of fish species in a nearby lake. The findings were made in a provincial government study posted online May 27. The paper is awaiting peer review. The scientists who authored it were not made available to speak to reporters. The other authors not employed by the province did not respond to requests for comment. Alberta has responded to the study with an advisory saying people should consider "limiting consumption" of three fish species drawn from Crowsnest Lake, a fishing spot downstream from the coal mines. Those species were found to have dangerously high levels of selenium, a mineral found in coal-rich deposits, in their body tissue. The authors write the study shows that "biological impacts of (mountaintop removal) coal mining can persist long after mining operations end." They suggest that "any further coal mine development may well push the Crowsnest fishery beyond sustainability.' The study comes after the Alberta Energy Regulator, or AER, granted an Australia-based coal company permission to start a controversial coal exploration on the eastern slopes. The project was initially rejected in 2021 when a panel ruled the likely environmental effects on fish and water quality outweighed potential economic benefits. But the regulator said last month it's possible there will be runoff from the nearby pit lake that Northback Holding Corp. is using. It ultimately concluded the project won't have any effect on the water quality downstream. The AER said that "out of an abundance of caution," Northback will have to comply with a directive for managing drilling waste in response to concerns over selenium. The new study measured selenium levels in fish from Crowsnest Lake, which is fed by creeks connected to Tent Mountain and Grassy Mountain – both former coal mine sites. Alberta has a fish tissue selenium guideline of four micrograms per gram. The authors write that every single fish sample analyzed exceeded this value. Average selenium concentrations were highest in Brown Trout, coming in at 18 micrograms per gram. The authors write that the selenium levels could lead to 'behavioural changes, physical symptoms ... respiratory issues, reproductive issues and ultimately population collapse." Accumulating fluid in body tissue or fin and tail damage are among other side effects. Most people are exposed to healthy levels of selenium through grains and flours, but Health Canada says elevated consumption can lead to hair loss, decreased cognitive function and gastrointestinal disorders. The high selenium concentrations can only be explained by "the incorporation of legacy coal mine pollution,' the authors write. The study goes on to say selenium levels in fish in Crowsnest Lake are similar to those found in water bodies near Fernie, B.C., that resulted in Teck Mining Company, which owned and operated a nearby mine, being forced in 2021 by B.C. provincial court to pay a $60 million fine – the largest fine ever imposed under the Fisheries Act. Fish populations in those mining-impacted streams were found in 2011 to have an average selenium concentration of 7.6 micrograms per gram. Nine years later, the adult westslope cutthroat population had suffered a 93 per cent decline, the study says. The authors conclude that factors including the emergence of Whirling Disease, drought conditions, high fishing activity -- and now high selenium levels in fish -- make the Crowsnest Lake and River "an especially vulnerable system.' 'Any new development of coal mining along the eastern slopes may well push the Crowsnest fishery beyond recovery,' they write. Colin Cooke, one of the authors, published a 2024 study that found a former coal mine in the Crowsnest River watershed was releasing selenium to fish at rates more than dozens of times higher than federal and provincial guidelines. Cooke is a senior aquatic scientist with the Alberta government, according to LinkedIn. Peter Doyle, CEO of Evolve Power Ltd., formerly Montem Resources Ltd., which previously sought to restart an old mine on Tent Mountain, said in an email that the company is complying with terms set out by the AER. "As reflected in other work by the author, there are numerous contributors to water quality in the Crowsnest River valley, not related to Tent Mountain, including changes in upstream conditions, changes in weathering rates and other anthropogenic changes in the watershed," Doyle wrote, referring to Cooke's 2024 study. That report notes those factors, among others, could be contributing to contaminant levels and concluded that coal mining activities in the Crowsnest River watershed "have been impacting ecosystems downstream for decades." Northback, in an email, wrote that Crowsnest Lake is unrelated to its Grassy Mountain project. "However, with our own project, Northback is committed to adhering to the highest environmental standards and ensuring a safe water supply." Ryan Fournier, press secretary for Alberta's environment ministry, deferred questions about monitoring and enforcement to the AER. He said the province is funding a series of studies and submitting them to peer-reviewed academic journals as the province revises its coal policy. He also said the authors were not available to speak to media because they "are not trained spokespeople." The AER told The Canadian Press that it has directed Evolve Power, the Tent Mountain owner, to submit a "selenium management plan proposal" that targets reductions in selenium in mine-affected water. Evolve was to submit that plan by July 31 of last year, but the AER said it granted the company an extension to March 31, 2026. The energy regulator also said that while selenium levels are elevated, "there is no evidence of non-compliance on monitoring or selenium management requirements at this time." The province announced in December it would allow coal mining to take place in Alberta under certain conditions. However, it exempted Northback and Evolve Power's projects from those rules because they were considered "advanced." Fisheries and Oceans Canada said in a statement that it doesn't comment on provincial permitting decisions and it hasn't been asked to review the local impacts to wildlife in the area. This report by The Canadian Press was first published June 6, 2025. Matthew Scace, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
HistoSonics completes pivotal histotripsy system trial enrolment
As reports of an acquisition by one of the leading players in the medical device space percolate, HistoSonics has completed enrolment in a pivotal trial to evaluate its histotripsy platform in treating kidney tumours. The US company's prospective, multi-centre, single-arm pivotal #HOPE4KIDNEY (NCT05820087) trial is designed to evaluate the effectiveness and safety of the Edison system for the destruction of kidney tissue by treating primary solid renal tumours. A total of 67 patients have been enrolled with a single, non-metastatic solid kidney mass ≤3cm. Patients will be treated with the Edison system and followed for five years post-procedure, with data at the 90-day evaluation point to be submitted in support of regulatory approval with the US Food and Drug Administration (FDA). The Edison system uses a technology called histotripsy, involving the delivery of non-thermal, non-invasive focused ultrasound waves to target and eliminate cancerous liver tissue. The system received de novo clearance from the US Food and Drug Administration (FDA) in 2023 and last month secured its first major insurance coverage from a new healthcare policy from Healthcare payor Blue Cross Blue Shield of Michigan (BCBSM) and health plan option Blue Care Network. HistoSonics' vision is for its Edison system to become a 'foundational, non-invasive' solution across a range of clinical applications, the company's CEO, Mike Blue stated. 'Completing enrolment in our pivotal kidney tumour trial represents a significant milestone toward that goal and reinforces our confidence in expanding histotripsy into additional tumour types and indications,' said Blue. In May, Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet Clinical Need Authorisation (UCNA) under the UK's Innovative Devices Access Pathway (IDAP), launched by the UK Government in 2023 to help fast-track 'transformative medical technologies' into the healthcare system. As first reported by the Financial Times last month, HistoSonics is seeking a valuation of more than $2.5bn for a takeover of the company, with Medtronic, GE HealthCare and Johnson & Johnson (J&J), a longtime backer of HistoSonics, among the interested parties evaluating the business. J&J most recently participated in HistoSonics' $102m Series D funding round. "HistoSonics completes pivotal histotripsy system trial enrolment" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
